First human trial of NS-136 in healthy volunteers
Treatments studied
This study tests a new medication called NS-136 for the first time in people. It aims to see how safe and tolerable the drug is when given to healthy adults. If you are generally healthy, you may be able to take part and help researchers learn about this potential new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a body mass index (a measure of weight relative to height) between 18 and 32.
- You must be in good general health, with no major medical conditions.
- You cannot have taken part in another clinical trial in the last 30 days (or longer for some drugs).
- Women who could become pregnant must have a negative pregnancy test and use birth control for 90 days after the last dose; men must also use birth control for 90 days.
- You must not smoke more than 5 cigarettes per day and be willing to stop smoking during the trial.
- You must not drink more than 14 units of alcohol per week (roughly 7 standard drinks) and be willing to avoid alcohol during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a new medication (NM-101) in healthy male volunteers to see how the body handles it and if it's safe. It is a phase 1 study that requires you to be in good health and have no major medical conditions.
This study tests an experimental drug called NS-079 in healthy people to see how safe it is and how the body processes it. It may help researchers learn if the drug could be used for future treatments.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a new drug called SNH-119014 for the first time in humans. It involves healthy volunteers to check the drug's safety and how the body processes it. It may be a step toward a new treatment for certain conditions.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.